CRIS Current Research Information System

GRAZI, GIAN LUCA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 12.201
EU - Europa 7.870
AS - Asia 3.442
AF - Africa 556
SA - Sud America 23
OC - Oceania 12
Continente sconosciuto - Info sul continente non disponibili 7
Totale 24.111
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 12.173
GB - Regno Unito 2.543
DE - Germania 1.089
SE - Svezia 1.084
VN - Vietnam 1.026
CN - Cina 1.022
IT - Italia 865
SG - Singapore 720
UA - Ucraina 622
IN - India 468
FR - Francia 381
IE - Irlanda 346
RU - Federazione Russa 320
EE - Estonia 195
ZA - Sudafrica 186
TG - Togo 180
CH - Svizzera 124
CI - Costa d'Avorio 112
BG - Bulgaria 80
JO - Giordania 71
FI - Finlandia 49
JP - Giappone 43
BE - Belgio 42
SC - Seychelles 38
NG - Nigeria 37
IR - Iran 33
CA - Canada 26
GR - Grecia 26
NL - Olanda 22
RO - Romania 20
ES - Italia 15
LB - Libano 13
HR - Croazia 11
BR - Brasile 10
AU - Australia 9
IL - Israele 9
CL - Cile 8
UZ - Uzbekistan 8
HK - Hong Kong 7
AT - Austria 6
EU - Europa 6
PL - Polonia 6
DK - Danimarca 4
PE - Perù 4
PT - Portogallo 4
CZ - Repubblica Ceca 3
HU - Ungheria 3
MY - Malesia 3
NO - Norvegia 3
NZ - Nuova Zelanda 3
TR - Turchia 3
LK - Sri Lanka 2
MM - Myanmar 2
PH - Filippine 2
RS - Serbia 2
TH - Thailandia 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AE - Emirati Arabi Uniti 1
AL - Albania 1
BD - Bangladesh 1
BO - Bolivia 1
DO - Repubblica Dominicana 1
ID - Indonesia 1
KE - Kenya 1
KH - Cambogia 1
KR - Corea 1
KW - Kuwait 1
KZ - Kazakistan 1
LI - Liechtenstein 1
LU - Lussemburgo 1
MD - Moldavia 1
MO - Macao, regione amministrativa speciale della Cina 1
MU - Mauritius 1
PR - Porto Rico 1
SI - Slovenia 1
TN - Tunisia 1
Totale 24.111
Salva come PNG Salva come JPEG
Città #
Southend 2.290
Fairfield 1.856
Chandler 1.103
Ashburn 951
Woodbridge 895
Wilmington 792
Seattle 777
Houston 739
Dong Ket 676
Cambridge 618
Singapore 615
Princeton 552
Ann Arbor 474
Jacksonville 400
Dublin 344
Westminster 251
Nanjing 223
Padova 217
Berlin 181
Lomé 180
Bologna 142
Santa Clara 134
Saint Petersburg 132
Abidjan 112
Bern 103
San Diego 103
Jinan 96
Shenyang 96
Sofia 80
Amman 71
Hebei 71
Nanchang 70
Mülheim 68
Dearborn 67
Des Moines 63
Beijing 61
Boardman 60
Changsha 60
Florence 60
Turin 54
Milan 49
New York 49
Helsinki 47
Norwalk 47
Los Angeles 46
Jiaxing 43
Tianjin 43
Brussels 41
Olalla 41
Falls Church 40
Mahé 38
Medford 37
Tokyo 37
Abeokuta 36
Verona 34
Haikou 28
Redwood City 28
Zhengzhou 28
Guangzhou 27
Bremen 25
Mountain View 23
London 22
Redmond 22
Ningbo 21
Taiyuan 20
Paris 19
Bühl 17
Monmouth Junction 17
Hangzhou 16
Toronto 16
Lanzhou 15
Leawood 15
Taizhou 13
Ardabil 11
Fuzhou 11
Kunming 11
Phoenix 11
Pune 10
San Francisco 10
Frankfurt Am Main 9
Frankfurt am Main 9
Groningen 9
Plauen 9
Buffalo 8
Hefei 8
Madrid 8
São Paulo 8
Tappahannock 8
Zanjan 8
Chicago 7
Edinburgh 7
Fort Worth 7
Provo 7
Sacramento 7
Tel Aviv 7
Amsterdam 6
Lausanne 6
Muizenberg 6
Orange 6
Rome 6
Totale 17.057
Salva come PNG Salva come JPEG
Nome #
Clinical trial: peg-interferon alfa-2b and ribavirin for the treatment of genotype-1 hepatitis C recurrence after liver transplantation 206
Absence of neuroinvasive disease in a liver transplant recipient who acquired West Nile virus (WNV) infection from the organ donor and who received WNV antibodies prophylactically. 201
Adjuvant, adoptive immunotherapy with tumor infiltrating lymphocytes plus interleukin-2 after radical hepatic resection for colorectal liver metastases: 5-year analysis. 189
Adjuvant systemic chemotherapy after putative curative resection of colorectal liver and lung metastases. 184
A new priority policy for patients with hepatocellular carcinoma awaiting liver transplantation within the model for end-stage liver disease system. 183
A new liver transplant priority for patients with hepatocellular carcinoma. 180
Aberrant Notch3 and Notch4 expression in human hepatocellular carcinoma. 175
Molecular Aging of Human Liver: An Epigenetic/Transcriptomic Signature 173
Comprehensive surgical intestinal rescue and transplantation program in adult patients: Bologna experience. 173
Identification of miR-31-5p, miR-141-3p, miR-200c-3p, and GLT1 as human liver aging markers sensitive to donor-recipient age-mismatch in transplants 171
Circulating and hepatic endocannabinoids and endocannabinoid-related molecules in patients with cirrhosis 168
Associated benign liver tumors in idiopathic granulomatous hepatitis: a case report 167
Causes of early acute graft failure after liver transplantation: analysis of a 17-year single-centre experience. 156
The peculiar aging of human liver: A geroscience perspective within transplant context 151
Can antiplatelet prophylaxis reduce the incidence of hepatic artery thrombosis after liver transplantation? 149
Changes in the surgical approach to hilar cholangiocarcinoma during an 18-year period in a Western single center 149
Analysis of factors affecting recurrence of hepatocellular carcinoma after liver transplantation with a special focus on inflammation markers. 148
Application of a fluorescent PCR method for molecular diagnosis of posttransplant lymphoproliferative disorders on routine tissue sections. 148
Combined heart and liver transplantation in four adults with familial amyloidosis: experience of a single center 145
Importance of primary indication and liver function between stages: Results of a multicenter Italian audit of ALPPS 2012-2014 144
Hepatitis C virus recurrence after liver transplantation: a 10-year evaluation. 143
CDKN1C/P57 Is Regulated by the Notch Target Gene Hes1 and Induces Senescence in Human Hepatocellular Carcinoma. 143
Assessment of donor steatosis in liver transplantation: is it possible without liver biopsy? 142
Comparison between the fifth and sixth editions of the AJCC/UICC TNM staging systems for hepatocellular carcinoma: multicentric study on 393 cirrhotic resected patients. 140
Lifelong maintenance of composition, function and cellular/subcellular distribution of proteasomes in human liver 140
Impact of model for end-stage liver disease (MELD) score on prognosis after hepatectomy for hepatocellular carcinoma on cirrhosis. 138
Cyclin G1 is a target of miR-122a, a microRNA frequently down-regulated in human hepatocellular carcinoma. 135
Liver allocation for hepatocellular carcinoma: a European Center policy in the pre-MELD era. 134
Italian experience in adult clinical intestinal and multivisceral transplantation: 6 years later. 134
Coping strategies in intestinal transplantation 133
Liver transplantation for hepatocellular carcinoma: further considerations on selection criteria. 132
Studies on immunoproteasome in human liver. Part I: absence in fetuses, presence in normal subjects, and increased levels in chronic active hepatitis and cirrhosis 132
Conventional split liver transplantation for two adult recipients: a recent experience in a single European center 132
Effect of different immunosuppressive schedules on recurrence-free survival after liver transplantation for hepatocellular carcinoma. 132
Anti-HBs re-seroconversion after liver transplantation in a patient with past HBV infection receiving a HBsAg positive graft 132
Daclizumab and Alemtuzumab as induction agents in adult intestinal and multivisceral transplantation: A comparison of two different regimens on 29 recipients during the early post-operative period. 132
12-month follow-up analysis of a multicenter, randomized, prospective trial in de novo liver transplant recipients (LIS2T) comparing cyclosporine microemulsion (C2 monitoring) and tacrolimus. 131
Efficacy of MELD score in predicting survival after liver retransplantation. 130
Histological recurrent hepatitis C after liver transplantation: Outcome and role of retransplantation. 130
The role of lymphadenectomy for liver tumors. Further considerations on the appropriateness of treatment strategy 129
Iliac Approach for Vascularization of an Intestinal Graft at Retransplantation. 129
CMV infection and biliary tract complications are related with a poor outcome of liver transplantation for HCV-related cirrhosis 129
ALPPS for primary and secondary liver tumors 129
Using Elderly Donors in Liver Transplantation. 128
Prognostic factors for tumor recurrence after a 12-year, single-center experience of liver transplantations in patients with hepatocellular carcinoma. 128
Alfa-fetoprotein in hepatocellular carcinoma (HCC): diagnostic and prognostic role, clinical and biological predictors. Analysis of 1099 patients. 127
Results of lis2t, a multicenter, randomized study comparing cyclosporine microemulsion with C2 monitoring and tacrolimus with C0 monitoring in de novo liver transplantation. 126
Incidence, clinical significance, and outcome of vascular alterations in intestinal biopsies after isolated small bowel transplantation: a single-center experience. 126
Daclizumab and alemtuzumab as induction agents in adult intestinal and multivisceral transplantation: rejection and infection rates in 40 recipients during the early postoperative period. 125
Criteria for diagnosing benign portal vein thrombosis in the assessment of patients with cirrhosis and hepatocellular carcinoma for liver transplantation. 125
Extramedullary myeloid tumour of the stomach and duodenum presenting without acute myeloblastic leukemia: a diagnostic and therapeutic challenge. 124
Comparison of recurrence of hepatocellular carcinoma after resection in patients with cirrhosis to its occurrence in a surveilled cirrhotic population. 124
Long term follow-up and outcome of liver transplantation for alcoholic liver disease: a single center case-control study 123
Split-liver transplantation with pediatric donors: a multicenter experience. 121
Kidney transplantation combined with other organs in bologna: an update. 120
Surveillance for hepatocellular carcinoma in elderly italian patients with cirrhosis. Effects on cancer staging and patients survival. 119
Apoptotic epitope-specific CD8+ T cells and interferon signaling intersect in chronic Hepatitis C virus infection 118
Double-blind comparison of hepatitis C histological recurrence Rate in HCV+ Liver transplant recipients given basiliximab + steroids or basiliximab + placebo, in addition to cyclosporine and azathioprine. 117
Incidence and management of abdominal closure-related complications in adult intestinal transplantation. 117
Partial necrosis on hepatocellular carcinoma nodules facilitates tumor recurrence after liver transplantation. 116
Liver transplantation for recurrent hepatocellular carcinoma on cirrhosis after liver resection: University of Bologna experience. 115
Survival Benefit After Liver Transplantation: A Single European Center Experience 115
Outcome of hepatic artery reconstruction in liver transplantation with an iliac arterial interposition graft. 115
Expression of connective tissue growth factor is a prognostic marker for patients with intrahepatic cholangiocarcinoma 114
MicroRNA-221 targets Bmf in hepatocellular carcinoma and correlates with tumor multifocality. 113
Portal vein thrombosis and liver transplantation: evolution during 10 years of experience at the University of Bologna. 113
Detection of recipient's cells in liver graft using antibodies to mismatched HLA class I antigens 113
Rejection episodes and 3-year graft survival under sirolimus and tacrolimus treatment after adult intestinal transplantation. 113
17. Other Malignant Primary Tumors of the Liver 113
MiR-122/Cyclin G1 Interaction Modulates p53 Activity and Affects Doxorubicin Sensitivity of Human Hepatocarcinoma Cells. 112
Safety and prognostic role of regional lymphadenectomy for primary and metastatic liver tumors. 112
Intrahepatic cholangiocarcinoma: primary liver resection and aggressive multimodal treatment of recurrence significantly prolong survival. 112
A bioluminescent mouse model of proliferation to highlight early stages of pancreatic cancer: A suitable tool for preclinical studies 111
A partnership model between high- And low-volume hospitals to improve results in hepatobiliary pancreatic surgery 111
Preoperative prediction of hepatocellular carcinoma tumour grade and micro-vascular invasion by means of artificial neural network: a pilot study. 110
Liver and partial atrium transplantation for chronic Budd-Chiari syndrome. 110
Comparative pre-and intraoperative imaging evaluation in patients with colorectal liver metastases: A prospective study on 128 resected metastases. 109
Second surgery or chemotherapy for relapse after radical resection of colorectal cancer metastases. 108
The pattern of hMENA isoforms is regulated by TGF-β1 in pancreatic cancer and may predict patient outcome 108
Impact of biliary complications in right lobe living donor liver transplantation. 107
Harm and benefits of primary liver resection and salvage transplantation for hepatocellular carcinoma. 107
MiR-199a-3p regulates mTOR and c-Met to influence the doxorubicin sensitivity of human hepatocarcinoma cells. 106
Liver transplantation from hepatitis B surface antigen positive donors: a safe way to expand the donor pool. 106
Successful treatment of rhinomaxillary form of mucormycosis infection after liver transplantation: a case report 105
The role of liver resections for metastases from lung carcinoma. 105
Improving the outcome of liver transplantation with very old donors with updated selection and management criteria. 105
GADD45alpha expression in cirrhosis and hepatocellular carcinoma. Relationship with DNA-repair and proliferation. 105
Liver transplantations with donors aged 60 years and above: the low liver damage strategy 105
Psychological Adaptation and Quality of Life of Adult Intestinal Transplant Recipients: University of Bologna Experience 105
Can Hepatocellular Carcinoma tumor grade and microscopical vascular invasion be predicted with an artificial neural network? 105
Impact of etiology of cirrhosis on the survival of patients diagnosed with hepatocellular carcinoma during surveillance. 104
Effect of liver transplantation on tuftsin activity and phagocytic activity of neutrophyl granulocytes in patients with liver cirrhosis. 104
Impact of induction therapy on bacterial infections and long-term outcome in adult intestinal and multivisceral transplantation: a comparison of two different induction protocols: daclizumab vs. alemtuzumab. 104
Kidney transplantation combined with other organs: experience of bologna s. Orsola hospital. 103
ORGAN-SPECIFIC BIOMARKERS OF HUMAN AGING: THE CASE OF LIVER 103
Liver transplantation for hepatocellular carcinoma under calcineurin inhibitors: reassessment of risk factors for tumor recurrence. 102
A Novel Nomogram to Predict the Prognosis of Patients Undergoing Liver Resection for Neuroendocrine Liver Metastasis: an Analysis of the Italian Neuroendocrine Liver Metastasis Database 102
Profiles of cancer stem cell subpopulations in cholangiocarcinomas 102
Modification of Acid-Base Balance in Cirrhotic Patients Undergoing Liver Resection for Hepatocellular Carcinoma. 101
Variable activation of phosphoinositide 3-kinase influences the response of liver grafts to ischemic preconditioning. 101
Totale 12.839
Salva come PNG Salva come JPEG
Categoria #
all - tutte 64.165
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 64.165
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20205.839 0 0 85 404 721 758 894 921 974 470 256 356
2020/20213.702 787 296 125 188 74 162 92 169 278 196 176 1.159
2021/20224.519 445 183 348 399 413 247 100 307 135 244 931 767
2022/20234.845 526 754 253 633 264 340 141 317 848 132 402 235
2023/20241.081 93 248 73 110 79 161 47 74 28 74 44 50
2024/20251.164 183 889 92 0 0 0 0 0 0 0 0 0
Totale 24.642